Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pill
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The pill,…
Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. The pill,…
Multiple independent virologists and disease experts told Reuters that the two new antiviral drugs function differently when compared to Ivermectin….
The FDA authorized the Pfizer vaccine for elementary school-aged children aged 5 to 11 on Tuesday. The decision comes after…
A new oral drug being produced by Pfizer is not a repackaged version of the antibacterial medication often used to…
On Monday, US President Joe Biden received a booster shot of the Pfizer COVID-19 vaccine. The US Food and Drug…
A panel of CDC advisers unanimously recommended that Pfizer recipients 65 and older, and others at risk of severe COVID,…
Pfizer’s coronavirus vaccine is safe and highly effective in young children aged 5 to 11, the company said. If FDA…
A panel of expert outside advisers to the U.S. FDA voted to recommend COVID-19 vaccine booster shots for Americans. Who…
The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of…
Dr. Kathrin Jansen, Pfizer head of vaccine development, told The New York Times that Pfizer was never a part of…
English▼
